000 01532 a2200361 4500
005 20250515102659.0
264 0 _c20080331
008 200803s 0 0 eng d
022 _a1198-743X
024 7 _a10.1111/j.1469-0691.2007.01867.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRossolini, G M
245 0 0 _aThe spread of CTX-M-type extended-spectrum beta-lactamases.
_h[electronic resource]
260 _bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
_cJan 2008
300 _a33-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnti-Bacterial Agents
_xmetabolism
650 0 4 _aCefotaxime
_xmetabolism
650 0 4 _aCeftazidime
_xmetabolism
650 0 4 _aCeftriaxone
_xmetabolism
650 0 4 _aCephalosporins
_xmetabolism
650 0 4 _aEnterobacteriaceae
_xdrug effects
650 0 4 _aEnterobacteriaceae Infections
_xepidemiology
650 0 4 _aHumans
650 0 4 _aModels, Molecular
650 0 4 _aPrevalence
650 0 4 _abeta-Lactam Resistance
_xgenetics
650 0 4 _abeta-Lactamases
_xchemistry
700 1 _aD'Andrea, M M
700 1 _aMugnaioli, C
773 0 _tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
_gvol. 14 Suppl 1
_gp. 33-41
856 4 0 _uhttps://doi.org/10.1111/j.1469-0691.2007.01867.x
_zAvailable from publisher's website
999 _c17666131
_d17666131